1. Tompkins BA, DiFede DL, Khan A, Landin AM, Schulman IH, Pujol MV, et al. Allogeneic mesenchymal stem cells ameliorate aging frailty: A phase II randomized, double-blind, placebo-controlled clinical trial. J Gerontol Ser A 2017; 72: 1513–1522.
2. Zhu Y, Huang C, Zheng L, Li Q, Ge J, Geng S, et al. Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: A phase I/II randomized, double-blind, placebo-controlled study. Stem Cell Res Ther 2024; 15: 122.
3. Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N, et al. Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: A randomized clinical trial. JAMA Netw Open 2020; 3: e2020836.
4. McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, et al. Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): A multicentere, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 2022; 399: 1049-1058.
5. Siemionow M, Biegański G, Niezgoda A, Wachowiak J, Czarnota J, Siemionow K, et al. Safety and efficacy of DT-DEC01 therapy in duchenne muscular dystrophy patients: A 12 - month follow-up study after systemic intraosseous administration. Stem Cell Rev Rep 2023; 19: 2724–2740.
6. Vale D, Pereira A, Andrade JP, Castro JP. The role of platelet-rich plasma injection for muscle strains in athletes. Cureus 2024; 16: e60585.
7. Murray IR, Makaram NS, Rodeo SA, Safran MR, Sherman SL, McAdams TR, et al. Biologics in professional and Olympic sport: A scoping review. Bone Jt J 2021; 103: 1189–1196.
8. Dziki J, Badylak S, Yabroudi M, Sicari B, Ambrosio F, Stearns K, et al. An acellular biologic scaffold treatment for volumetric muscle loss: Results of a 13-patient cohort study. NPJ Regen Med 2016; 1: 16008.
9. Le NT, Dunleavy MW, Zhou W, Bhatia SS, Kumar RD, Woo ST, et al. Stem cell therapy for myocardial infarction recovery: Advances, challenges, and future directions. Biomedicines 2025; 13: 1209.
10. Muhammad SA, Nordin N, Mehat MZ, Fakurazi S. Comparative efficacy of stem cells and secretome in articular cartilage regeneration: A systematic review and meta-analysis. Cell Tissue Res 2019; 375: 329–344.
11. Neculachi CA, Leti LI, Burlacu A, Preda MB. Inflammation and hypoxia negatively impact the survival and immunosuppressive properties of mesenchymal stromal cells in vitro. Romanian J Cardiol 2021; 31: 547-554.
12. Mueller AL, Bloch RJ. Skeletal muscle cell transplantation: Models and methods. J Muscle Res Cell Motil 2020; 41: 297-311.
13. Dhariwal R, Jain M, Mir YR, Singh A, Jain B, Kumar P, et al. Targeted drug delivery in neurodegenerative diseases: The role of nanotechnology. Front Med 2025; 12: 1522223.
14. Teng H, Sun X, Jiang C, Liu A, Liu X, Chen Y, et al. Ultrasound measurements of skeletal muscle predict chemotherapy toxicity in non-small cell lung cancer. Nutr Cancer 2025; 77: 861-870.
15. Calin G, Costescu M, Nour (Cârlig) M, Ciuhodaru T, Denisa B-M, Duceac LD, et al. Engineered hydrogels for musculoskeletal regeneration: Advanced synthesis strategies and therapeutic efficacy in preclinical models. Polymers 2025; 17: 2094.
16. Huang Z, Cheng J, Su W. A double cross-linked injectable hydrogel derived from muscular decellularized matrix promotes myoblast proliferation and myogenic differentiation. Materials 2023; 16: 5335.
17. Yuan C, Yan X, Yue K, Wang H, Zhang X, Yan D, et al. Optimization of surgical parameters for liver tumor microwave ablation assisted by hydrodissection: Solution space features and active learning approach. Comput Methods Programs Biomed 2025; 270: 108967.
18. Khan K, Gasbarrino K, Mahmoud I, Dufresne L, Daskalopoulou SS, Schwertani A, et al. Bioactive scaffolds in stem cell-based therapies for myocardial infarction: A systematic review and meta-analysis of preclinical trials. Stem Cell Rev Rep 2022; 18: 2104-2136.
19. Muir LA, Murry CE, Chamberlain JS. Prosurvival factors improve functional engraftment of myogenically converted dermal cells into dystrophic skeletal muscle. Stem Cells Dev 2016; 25: 1559-1569.
20. Davoudi S, Chin C-Y, Cooke MJ, Tam RY, Shoichet MS, Gilbert PM. Muscle stem cell intramuscular delivery within hyaluronan methylcellulose improves engraftment efficiency and dispersion. Biomaterials 2018; 173: 34-46.
21. Abat F, Campos J, Torras J, Madruga M, Planells G, Rodriguez-Baeza A. Comparison of ultrasound-guided versus blind interventions for supraspinatus tendinopathy: a cadaveric study. Muscle Ligaments Tendons J 2019; 09: 328.
22. Fujimoto K, Kanamoto T, Otani S, Miyazaki R, Ebina K, Nakata K. Basic research for ultrasound-guided injection into skeletal muscle lesions in an experimental animal model. Bone Jt Res 2025; 14: 33-41.
23. Palermi S, Scavone A, Anzà M, Gregorace E, Vecchiato M, Bordalo M, et al. Diagnostic ultrasound of muscle injuries: What the sports medicine clinician should know. Br J Sports Med 2025; 59: bjsports-2025-110255.
24. Albano D, Aringhieri G, Messina C, De Flaviis L, Sconfienza LM. High-frequency and ultra-high frequency ultrasound: Musculoskeletal imaging up to 70 MHz. Semin Musculoskelet Radiol 2020; 24: 125-134.
25. Dias AC, Jureidini RAG, Araujo-Filho JAB, Camerin GR, Zattar LC, Sernik RA, et al. Advanced US of the skin, nerves, and muscles of the neck: Pearls and pitfalls with use of high-frequency transducers. RadioGraphics 2024; 44: e240029.
26. Babaei S, Dai B, Abbey CK, Ambreen Y, Dobrucki WL, Insana MF. Monitoring muscle perfusion in rodents during short-term ischemia using power doppler ultrasound. Ultrasound Med Biol 2023; 49: 1465-1475.
27. Becker AB, Chen L, Ning B, Hu S, Hossack JA, Klibanov AL, et al. Contrast-enhanced ultrasound reveals partial perfusion recovery after hindlimb ischemia as opposed to full recovery by laser doppler perfusion imaging. Ultrasound Med Biol 2022; 48: 1058-1069.
28. Martins-Bach AB, Bachasson D, Araujo ECA, Soustelle L, Loureiro De Sousa P, Fromes Y, et al. Non-invasive assessment of skeletal muscle fibrosis in mice using nuclear magnetic resonance imaging and ultrasound shear wave elastography. Sci Rep 2021; 11: 284.
29. Leiva-Cepas F, Benito-Ysamat A, Jimena I, Jimenez-Diaz F, Gil-Belmonte MJ, Ruz-Caracuel I, et al. Ultrasonographic and histological correlation after experimental reconstruction of a volumetric muscle loss injury with adipose tissue. Int J Mol Sci 2021; 22: 6689.
30. De Castro JC. Regenerative Medicine Procedures Under Ultrasound Guidance. In: El Miedany Y, editor. Musculoskelet Ultrasound-Guid Regen Med. Cham: Springer International Publishing; 2022. p. 287-342.
31. Kamal MdN, Shakoor MA, Chowdhury ZR, Azad AK, Rahman N. Comparative analysis of musculoskeletal ultrasonography versus MRI in diagnosing shoulder injuries. SAS J Med 2024; 10: 924-929.
32. Shen P-C, Lin T-Y, Wu W-T, Özçakar L, Chang K-V. Comparison of ultrasound- vs. landmark-guided injections for musculoskeletal pain: an umbrella review. J Rehabil Med 2024; 56: jrm40679.
33. Hoeber S, Aly A-R, Ashworth N, Rajasekaran S. Ultrasound-guided hip joint injections are more accurate than landmark-guided injections: A systematic review and meta-analysis. Br J Sports Med 2016; 50: 392-396.
34. Kimura R, Yamamoto N, Watanabe J, Ono Y, Hongo M, Miyakoshi N. Comparative efficacy of ultrasound guidance and fluoroscopy or computed tomography guidance in spinal nerve injections: A systematic review and meta-analysis. Eur Spine J 2023; 32: 4101-4110.
35. Plaikner M, Kögl N, Gruber H, Bale R, Ho WM, Skalla-Oberherber E, et al. Ultrasound-guided versus computed tomography-controlled periradicular injections of the first sacral nerve: A prospective randomized clinical trial. Med Ultrason 2023; 25: 35.
36. Ahmed S, Subramanian A, Siddiqi A, Ramachandran V, Kaynat B, Masood M, et al. Comparing ultrasound and computed tomography in regional anesthesia: Real-time precision or radiologic clarity? Cureus 2025; 17: e87918
37. Tan ESJ, Tan YR, Liu CWY. Efficacy of perineural versus intravenous dexamethasone in prolonging the duration of analgesia when administered with peripheral nerve blocks: A systematic review and meta-analysis. Korean J Anesthesiol 2022; 75: 255-265.
38. Hou W-H, Lin P-C, Tung K-M, Chen S-R. Effectiveness of amnion allograft injections in patients with degenerative musculoskeletal diseases: A systematic review and meta-analysis. Am J Phys Med Rehabil. 2025; 104: 567-575.
39. Filippiadis DK, Efthymiou E, Palialexis K, Brountzos E, Kelekis N. Interventional oncology procedures for breast cancer metastatic disease: Current role and clinical applications. Diagn Interv Radiol 2022; 28: 249-256.
40. Arias-Buría JL, Borrella-Andrés S, Rodríguez-Sanz J, López-de-Celis C, Malo-Urriés M, Fernández-de-las-Peñas C, et al. Precision and safety of ultrasound-guided versus palpation-guided needle placement on the patellar tendon: A cadaveric study. Life 2023; 13: 2060.
41. Sahrmann AS, Vosse L, Siebert T, Handsfield GG, Röhrle O. 3D ultrasound-based determination of skeletal muscle fascicle orientations. Biomech Model Mechanobiol 2024; 23: 1263-1276.
42. Weide G, Van Der Zwaard S, Huijing PA, Jaspers RT, Harlaar J. 3D ultrasound imaging: Fast and cost-effective morphometry of musculoskeletal tissue. J Vis Exp 2017; 129: 55943.
43. Ritsche P, Ledergerber R, Pansini M, Santini F, Faude O. Assessment of lower limb muscle volume using 3D ultrasonography: Validity and reliability compared to MRI. J Imaging Inform Med 2026; 39: 1507-1518.
44. Adriaans CA, Wijkhuizen M, Van Karnenbeek LM, Geldof F, Dashtbozorg B. Trackerless 3D freehand ultrasound reconstruction: A review. Appl Sci 2024; 14: 7991.
45. Viderman D, Dossov M, Seitenov S, Lee MH. Artificial intelligence in ultrasound-guided regional anesthesia: A scoping review. Front Med 2022; 9: 994805.
46. Bowness J, El‐Boghdadly K, Burckett‐St Laurent D. Artificial intelligence for image interpretation in ultrasound‐guided regional anaesthesia. Anaesthesia 2021; 76: 602-607.
47. Ábrigo J, Simon F, Cabrera D, Cabello-Verrugio C. Angiotensin-(1-7) prevents skeletal muscle atrophy induced by transforming growth factor type beta (TGF-β) via mas receptor activation. Cell Physiol Biochem 2016; 40: 27-38.
48. Delaney K, Kasprzycka P, Ciemerych MA, Zimowska M. The role of TGF‐β1 during skeletal muscle regeneration. Cell Biol Int 2017; 41: 706–715.
49. Gallardo FS, Cruz-Soca M, Bock-Pereda A, Faundez-Contreras J, Gutiérrez-Rojas C, Gandin A, et al. Role of TGF-β/SMAD/YAP/TAZ signaling in skeletal muscle fibrosis. Am J Physiol-Cell Physiol 2025; 328: C1015-1028.
50. Gonzalez D, Contreras O, Rebolledo DL, Espinoza JP, Van Zundert B, Brandan E. ALS skeletal muscle shows enhanced TGF-β signaling, fibrosis and induction of fibro/adipogenic progenitor markers. Asakura A, editor. PLoS One. 2017; 12: e0177649.
51. Stepien DM, Hwang C, Marini S, Pagani CA, Sorkin M, Visser ND, et al. Tuning macrophage phenotype to mitigate skeletal muscle fibrosis. J Immunol 2020; 204: 2203-2215.
52. Thooyamani AS, Mukhopadhyay A. PDGFRα mediated survival of myofibroblasts inhibit satellite cell proliferation during aberrant regeneration of lacerated skeletal muscle. Sci Rep 2021; 11: 63.
53. Hara M, Yokota K, Saito T, Kobayakawa K, Kijima K, Yoshizaki S, et al. Periostin promotes fibroblast migration and inhibits muscle repair after skeletal muscle injury. J Bone Jt Surg 2018; 100: e108.
54. Mahdy MAA. Glycerol-induced injury as a new model of muscle regeneration. Cell Tissue Res 2018; 374: 233-241.
55. Højfeldt G, Hoegsbjerg C, Von Keudell AG, Mackey AL. The repair capacity spectrum of human skeletal muscle injury from sports to surgical trauma settings. J Physiol 2025; 603: 7441-7454.
56. Sinha S, Sparks HD, Labit E, Robbins HN, Gowing K, Jaffer A, et al. Fibroblast inflammatory priming determines regenerative versus fibrotic skin repair in reindeer. Cell 2022; 185: 4717-4736.
57. Endo Y, Hwang CD, Zhang Y, Olumi S, Koh DJ, Zhu C, et al. VEGFA promotes skeletal muscle regeneration in aging. Adv Biol 2023; 7: 2200320.
58. Hwang CD, Endo Y, Zhang Y, Neppl RL, Agarwal S, Sinha I. Aging associated loss of vegfa impairs muscle regeneration. Plast Reconstr Surg 2022; 10: 64.
59. Verma M, Asakura Y, Murakonda BSR, Pengo T, Latroche C, Chazaud B, et al. Muscle satellite cell cross-talk with a vascular niche maintains quiescence via VEGF and notch signaling. Cell Stem Cell 2018; 23: 530-543.
60. Yang C, Zhang L, Liu L, Bai L, Liu Y, Wang R, et al. Advances in vascular endothelial cell-mediated regulation of satellite cell repair and regeneration. Inflamm Regen 2025; 45: 30.
61. Nederveen JP, Betz MW, Snijders T, Parise G. The importance of muscle capillarization for optimizing satellite cell plasticity. Exerc Sport Sci Rev 2021; 49: 284-290.
62. Mohiuddin M, Lee NH, Moon JY, Han WM, Anderson SE, Choi JJ, et al. Critical limb ischemia induces remodeling of skeletal muscle motor unit, myonuclear-, and mitochondrial-domains. Sci Rep 2019; 9: 9551.
63. Sahinyan K, Lazure F, Blackburn DM, Soleimani VD. Decline of regenerative potential of old muscle stem cells: Contribution to muscle aging. FEBS J 2023; 290: 1267-1289.
64. Henze H, Jung MJ, Ahrens HE, Steiner S, Von Maltzahn J. Skeletal muscle aging – Stem cells in the spotlight. Mech Ageing Dev 2020; 189: 111283.
65. Blau HM, Cosgrove BD, Ho ATV. The central role of muscle stem cells in regenerative failure with aging. Nat Med 2015; 21: 854-862.
66. Chen W, Datzkiw D, Rudnicki MA. Satellite cells in ageing: Use it or lose it. Open Biol 2020; 10: 200048.
67. He Y, Xie W, Li H, Jin H, Zhang Y, Li Y. Cellular senescence in sarcopenia: Possible mechanisms and therapeutic potential. Front Cell Dev Biol 2022; 9: 793088.
68. García-Prat L, Martínez-Vicente M, Perdiguero E, Ortet L, Rodríguez-Ubreva J, Rebollo E, et al. Autophagy maintains stemness by preventing senescence. Nature 2016; 529: 37-42.
69. Snijders T, Aussieker T, Holwerda A, Parise G, Van Loon LJC, Verdijk LB. The concept of skeletal muscle memory: Evidence from animal and human studies. Acta Physiol 2020; 229: e13465.
70. White JP, Billin AN, Campbell ME, Russell AJ, Huffman KM, Kraus WE. The AMPK/p27Kip1 axis regulates autophagy/apoptosis decisions in aged skeletal muscle stem cells. Stem Cell Rep 2018; 11: 425-439.
71. Lacraz G, Rouleau A-J, Couture V, Söllrald T, Drouin G, Veillette N, et al. Increased stiffness in aged skeletal muscle impairs muscle progenitor cell proliferative activity. PLoS One 2015; 10: e0136217.
72. Stearns-Reider KM, D’Amore A, Beezhold K, Rothrauff B, Cavalli L, Wagner WR, et al. Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion. Aging Cell 2017; 16: 518-528.
73. Moiseeva V, Cisneros A, Sica V, Deryagin O, Lai Y, Jung S, et al. Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration. Nature 2023; 613: 169–178.
74. Rahman FA, Angus SA, Stokes K, Karpowicz P, Krause MP. Impaired ECM remodeling and macrophage activity define necrosis and regeneration following damage in aged skeletal muscle. Int J Mol Sci 2020; 21: 4575.
75. Helal MAM, Shaheen NEM, Abu Zahra FA. Immunomodulatory capacity of the local mesenchymal stem cells transplantation after severe skeletal muscle injury in female rats. Immunopharmacol Immunotoxicol 2016; 38: 414-422.
76. Zhang X, Zhang D, Zhang Y, Wang J, Lu J. Restoration of skeletal muscle function via mesenchymal stem cells: mechanistic insights and therapeutic advances in myasthenia gravis. Front Cell Dev Biol 2025; 13: 1658062.
77. Beegle J, Lakatos K, Kalomoiris S, Stewart H, Isseroff RR, Nolta JA, et al. Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo. Stem Cells 2015; 33: 1818-1828.
78. Kim M-J, Lim N-K, Choi S-J, Park H-Y. Hypertension is an independent risk factor for type 2 diabetes: The Korean genome and epidemiology study. Hypertens Res 2015; 38: 783-789.
79. Wang C, Zhao B, Zhai J, Wang A, Cao N, Liao T, et al. Clinical-grade human umbilical cord-derived mesenchymal stem cells improved skeletal muscle dysfunction in age-associated sarcopenia mice. Cell Death Dis 2023; 14: 321.
80. Hazrati A, Malekpour K, Soudi S, Hashemi SM. Mesenchymal stromal/stem cells spheroid culture effect on the therapeutic efficacy of these cells and their exosomes: A new strategy to overcome cell therapy limitations. Biomed Pharmacother 2022; 152: 113211.
81. Garg K, Brockhouse J, McAndrew CM, Reiter AJ, Owens JG, Mueller RJ, et al. Regenerative rehabilitation: Navigating the gap between preclinical promises and clinical realities for treating trauma‐induced volumetric muscle loss. J Physiol 2025; 603: 7421-7439.
82. Han WM, Anderson SE, Mohiuddin M, Barros D, Nakhai SA, Shin E, et al. Synthetic matrix enhances transplanted satellite cell engraftment in dystrophic and aged skeletal muscle with comorbid trauma. Sci Adv 2018; 4: eaar4008.
83. Tidball JG. Regulation of muscle growth and regeneration by the immune system. Nat Rev Immunol 2017; 17: 165-178.
84. Sun C, Serra C, Kalicharan BH, Harding J, Rao M. Challenges and considerations of preclinical development for iPSC-based myogenic cell therapy. Cells 2024; 13: 596.
85. Hamer MS, Rossi FMV. Multitasking muscle: Engineering iPSC-derived myogenic progenitors to do more. Front Cell Dev Biol 2025; 12: 1526635.
86. Murray IR, Baily JE, Chen WCW, Dar A, Gonzalez ZN, Jensen AR, et al. Skeletal and cardiac muscle pericytes: Functions and therapeutic potential. Pharmacol Ther 2017; 171: 65–74.
87. Avolio E, Meloni M, Spencer HL, Riu F, Katare R, Mangialardi G, et al. Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair. Circ Res 2015; 116: 81-94.
88. Zhou X, Li Z, Sun W, Yang G, Xing C, Yuan L. Delivery efficacy differences of intravenous and intraperitoneal injection of exosomes: Perspectives from tracking dye labeled and MiRNA encapsulated exosomes. Curr Drug Deliv 2020; 17: 186-194.
89. Chen H, Li Q. Recent advances in scalable exosome production: Challenges and innovations. Chin J Plast Reconstr Surg 2025; 7: 149–163.
90. Gai T, Zhang Y, Li G, Zhou F, He C, Wang X, et al. Engineered hydrogel microspheres for spheroids and organoids construction. Chem Eng J 2024; 498: 155131.
91. Urciuolo A, Urbani L, Perin S, Maghsoudlou P, Scottoni F, Gjinovci A, et al. Decellularised skeletal muscles allow functional muscle regeneration by promoting host cell migration. Sci Rep 2018; 8: 8398.
92. Ostrovidov S, Salehi S, Costantini M, Suthiwanich K, Ebrahimi M, Sadeghian RB, et al. 3D bioprinting in skeletal muscle tissue engineering. Small 2019; 15: 1805530.
93. Singh D, Kumar A. Next-generation nanocarriers for precision antitumor therapy: From passive targeting to intelligent response. Explor Target Antitumor Ther 2025; 6: 1002355.
94. Harrell CR, Sadikot R, Pascual J, Fellabaum C, Jankovic MG, Jovicic N, et al. Mesenchymal stem cell-based therapy of inflammatory lung diseases: Current understanding and future perspectives. Stem Cells Int 2019; 2019: 1-14.
95. Goel AJ, Rieder M-K, Arnold H-H, Radice GL, Krauss RS. Niche cadherins control the quiescence-to-activation transition in muscle stem cells. Cell Rep 2017; 21: 2236-2250.
96. Libergoli M, Almada AE. Stem cell aging and rejuvenation in the skeletal muscle system. Rejuvenation Res 2025; 28: 158-171.
97. Nakamura Y, Miyaki S, Ishitobi H, Matsuyama S, Nakasa T, Kamei N, et al. Mesenchymal‐stem‐cell‐derived exosomes accelerate skeletal muscle regeneration. FEBS Lett 2015; 589: 1257-1265.
98. Iyer SR, Scheiber AL, Yarowsky P, Henn RF, Otsuru S, Lovering RM. Exosomes isolated from platelet-rich plasma and mesenchymal stem cells promote recovery of function after muscle injury. Am J Sports Med 2020; 48: 2277-2286.
99. Abdelbary OA, Khalaf Megahed G, Hamam GG, Al- Khalek Ali HAA. The potential role of mesenchymal stem cells derived exosomes on the healing of grade II experimentally induced skeletal muscle injury in adult male albino rats. Histological study. QJM Int J Med 2023; 116: hcad069.345.
100. Hayashi H, Izumiya Y, Ishida T, Arima Y, Hayashi O, Yoshiyama M, et al. Exosomal miR206 secreted from growing muscle promotes angiogenic response in endothelial cells. Circ J 2024; 88: 425-433.
101. Luo Z, Lin J, Sun Y, Wang C, Chen J. Bone marrow stromal cell-derived exosomes promote muscle healing following contusion through macrophage polarization. Stem Cells Dev 2021; 30: 135-148.
102. Talebian S, Mehrali M, Taebnia N, Pennisi CP, Kadumudi FB, Foroughi J, et al. Self‐healing hydrogels: The next paradigm shift in tissue engineering? Adv Sci 2019; 6: 1801664.
103. Hayashi A. Ultra High Frequency Ultrasound. In: Hong JP, Lee BT, Hayashi A, Visconti G, editors. Imaging Reconstr Microsurg . Singapore: Springer Nature Singapore; 2024. p. 75-82.
104. Crawford SK, Lee KS, Bashford GR, Heiderscheit BC. Intra-session and inter-rater reliability of spatial frequency analysis methods in skeletal muscle. PLoS One 2020; 15: e0235924.
105. Watson J, Barker-Davies RM, Bennett AN, Fong DTP, Wheeler PC, Lewis M, et al. Sport and exercise medicine consultants are reliable in assessing tendon neovascularity using ultrasound Doppler. BMJ Open Sport Exerc Med 2018; 4: e000298.
106. Gilbert F, Klein D, Weng AM, Köstler H, Schmitz B, Schmalzl J, et al. Supraspinatus muscle elasticity measured with real time shear wave ultrasound elastography correlates with MRI spectroscopic measured amount of fatty degeneration. BMC Musculoskelet Disord 2017; 18: 549.
107. Arvind V, Nagahara E, Zhang H, Shyu P, Edward Guo X, Huang AH. Comparative analysis of tendon healing in a clinically relevant mouse model of achilles tendon repair. J Orthopaedic Res 2026; 44: e70173.
108. Huang Z, Du S, Qi Y, Chen G, Yan W. Effectiveness of ultrasound guidance on intraarticular and periarticular joint injections: Systematic review and meta-analysis of randomized trials. Am J Phys Med Rehabil 2015; 94: 775-783.
109. Pozza S, De Marchi A, Albertin C, Albano D, Biino G, Aloj D, et al. Technical and clinical feasibility of contrast-enhanced ultrasound evaluation of long bone non-infected nonunion healing. Radiol Med (Torino) 2018; 123: 703-709.
110. Jones EJ, Phillips BE. Methodologies to Quantify Skeletal Muscle Blood Flow/Perfusion. In: Atherton PJ, Wilkinson DJ, editors. Neuromuscul Assess Form Funct . New York, NY: Springer US; 2023. p. 299–315.
111. Colorado B, McNeill D, Norbury J. Ultrasound‐guided nerve hydrodissection for peripheral entrapment neuropathies. Muscle Nerve 2025; 72: 1052–1059.
112. Alptekin A, Khan MB, Parvin M, Chowdhury H, Kashif S, Selina FA, et al. Effects of low-intensity pulsed focal ultrasound-mediated delivery of endothelial progenitor-derived exosomes in tMCAo stroke. Front Neurol 2025; 16: 1543133.
113. Hebard S, Hocking G. Echogenic technology can improve needle visibility during ultrasound-guided regional anesthesia. Reg Anesth Pain Med 2011; 36: 185-189.
114. Li Z, Zhang Q, Zhang X, Jin Q, Yue Q, Li N, et al. Dihydroartemisinin inhibits melanoma migration and metastasis by affecting angiogenesis. Phytother Res 2025; 39: 1679-1693.
115. Belcik JT, Xie A, Qie Y, Giraud D, Abraham-Fen R-J, Varli O, et al. Influence of microbubble properties and carrier frequency on ultrasound cavitation-induced flow augmentation. J Am Soc Echocardiogr 2026; 39: 179-187.
116. Liu F, Su R, Jiang X, Wang S, Mu W, Chang L. Advanced micro/nano-electroporation for gene therapy: Recent advances and future outlook. Nanoscale 2024; 16: 10500-10521.
117. Wen X, Hao Y. The combined application of exosomes/exosome-based drug preparations and ultrasound. J Mater Chem B 2025; 13: 6626–6637.
118. Xu H, Huang Y, Zhang F, Shi W, Cheng Y, Yang K, et al. Ultrasonic microbubbles promote mesenchymal stem cell homing to the fibrotic liver via upregulation of CXCR4 expression. Cell Div 2024; 19: 7.
119. Cai P, Chen K, Qin X, Jiang X, Jiao X, Liu K, et al. Cationic microbubble loading hSIRT3 and hTIMP3 optimize cardiac-targeted delivery and myocardial protection in the porcine MI/R model. Mater Today Bio 2025; 34: 102234.
120. Bader KB, Padilla F, Haworth KJ, Ellens N, Dalecki D, Miller DL, et al. Overview of therapeutic ultrasound applications and safety considerations: 2024 update. J Ultrasound Med 2025; 44: 381-433.
121. Suzuki T, Sato T, Sukhbaatar A, Sakamoto M, Mori S, Kodama T, et al. Ultrasound irradiation in the presence of microbubbles may enhance the antitumor effect of chemotherapeutic agents against bladder cancer. J Cancer 2025; 16: 368-381.
122. Wang X, Martin G, Sadeghirad B, Chang Y, Florez ID, Couban RJ, et al. Common interventional procedures for chronic non-cancer spine pain: A systematic review and network meta-analysis of randomised trials. BMJ 2025; 388: e079971.
123. Lee K, Park JM, Yoon SY, Kim MS, Kim YW, Shin JI, et al. Ultrasound-guided nerve hydrodissection for the management of carpal tunnel syndrome: A systematic review and network meta-analysis. Yonsei Med J 2025; 66: 111.
124. Carstensen SMD, Velander MJ, Konge L, Østergaard M, Pfeiffer Jensen M, Just SA, et al. Training and assessment of musculoskeletal ultrasound and injection skills—a systematic review. Rheumatology 2022; 61: 3889-3901.
125. Stauffer T, Lohmeyer Q, Melamed S, Uhde A, Hostettler R, Wetzel S, et al. Evaluation of augmented reality training for a navigation device used for CT-guided needle placement. Int J Comput Assist Radiol Surg. 2024; 19: 2411–2419.
126. Hardy D, Besnard A, Latil M, Jouvion G, Briand D, Thépenier C, et al. Comparative study of injury models for studying muscle regeneration in mice. PLoS One 2016; 11: e0147198.
127. Nuutila K, Sakthivel D, Kruse C, Tran P, Giatsidis G, Sinha I. Gene expression profiling of skeletal muscle after volumetric muscle loss. Wound Repair Regen. 2017; 25: 408–413.
128. Genovese P, Patel A, Ziemkiewicz N, Paoli A, Bruns J, Case N, et al. Co‐delivery of fibrin‐laminin hydrogel with mesenchymal stem cell spheroids supports skeletal muscle regeneration following trauma. J Tissue Eng Regen Med 2021; 15: 1131-1143.
129. Rogers RG, Li L, Peck K, Sanchez L, Liu W, Ciullo A, et al. Cardiosphere-derived cells, with and without a biological scaffold, stimulate myogenesis and recovery of muscle function in mice with volumetric muscle loss. Biomaterials 2021; 274: 120852.
130. Liang W, Han M, Li G, Dang W, Wu H, Meng X, et al. Perfusable adipose decellularized extracellular matrix biological scaffold co-recellularized with adipose-derived stem cells and L6 promotes functional skeletal muscle regeneration following volumetric muscle loss. Biomaterials 2024; 307: 122529.
131. Sandonà M, Di Pietro L, Esposito F, Ventura A, Silini AR, Parolini O, et al. Mesenchymal stromal cells and their secretome: New therapeutic perspectives for skeletal muscle regeneration. Front Bioeng Biotechnol 2021; 9: 652970.
132. Bourgeois Yoshioka CK, Takenaka-Ninagawa N, Goto M, Miki M, Watanabe D, Yamamoto M, et al. Cell transplantation-mediated dystrophin supplementation efficacy in Duchenne muscular dystrophy mouse motor function improvement demonstrated by enhanced skeletal muscle fatigue tolerance. Stem Cell Res Ther 2024; 15: 313.
133. Fabre P, Molina T, Orfi Z, Dumont NA. Assessment of muscle function following hiPSC‐derived myoblast transplantation in dystrophic mice. Curr Protoc 2022; 2: e356.
134. Siemionow M, Budzynska K, Zalants K, Langa P, Brodowska S, Siemionow K, et al. Amelioration of morphological pathology in cardiac, respiratory, and skeletal muscles following intraosseous administration of human dystrophin expressing chimeric (DEC) cells in duchenne muscular dystrophy model. Biomedicines 2024; 12: 586.
135. Relaix F, Lafuste P, Taglietti V, Tiret L. The rise of rat models for Duchenne muscular dystrophy and therapeutic evaluations. Skelet Muscle 2025; 15: 26.
136. Praud C, Vauchez K, Zongo P, Vilquin J-T. Modelling human myoblasts survival upon xenotransplantation into immunodeficient mouse muscle. Exp Cell Res 2018; 364: 217-223. 137. Yu X, Bao B, Echigoya Y, Yokota T. Dystrophin-deficient large animal models: translational research and exon skipping. Am J Transl Res 2015; 7: 1314.
138. Bez M, Foiret J, Shapiro G, Pelled G, Ferrara KW, Gazit D. Nonviral ultrasound-mediated gene delivery in small and large animal models. Nat Protoc 2019; 14: 1015-1026.
139. Geng R, Knoll J, Harland N, Amend B, Enderle MD, Linzenbold W, et al. Replacing needle injection by a novel waterjet technology grants improved muscle cell delivery in target tissues. Cell Transplant 2022; 31: 09636897221080943.
140. Harland N, Johnen L, Avula KT, Buzanich-Ladinig A, Schwarz L, Knoll J, et al. The outcome of cell therapy treating urinary incontinence correlates with precise cell localization in the sphincter complex. Biomedicines 2025; 13: 917.
141. Tebebi PA, Burks SR, Kim SJ, Williams RA, Nguyen BA, Venkatesh P, et al. Cyclooxygenase-2 or tumor necrosis factor-α inhibitors attenuate the mechanotransductive effects of pulsed focused ultrasound to suppress mesenchymal stromal cell homing to healthy and dystrophic muscle. Stem Cells 2015; 33: 1173–1186.
142. Iorio EG, Khanteymoori A, Fond KA, Keller AV, Davis LM, Schwab JM, et al. Effect-size discrepancies in literature versus raw datasets from experimental spinal cord injury studies: A climber meta-analysis. Neurotrauma Rep 2024; 5: 686–698.
143. Meyer GA. Evidence of induced muscle regeneration persists for years in the mouse. Muscle Nerve 2018; 58: 858-862.
144. Augustine S, Avey MT, Harrison B, Locke T, Ghannad M, Moher D, et al. Mesenchymal stromal cell therapy in bronchopulmonary dysplasia: Systematic review and meta-analysis of preclinical studies. Stem Cells Transl Med 2017; 6: 2079-2093.
145. Schneider N, Sinnott M, Patel N, Joseph R. The use of platelet-rich plasma and stem cell injections in musculoskeletal injuries. Cureus 2024; 16: e59970.
146. Contreras-Muñoz P, Torrella JR, Venegas V, Serres X, Vidal L, Vila I, et al. Muscle precursor cells enhance functional muscle recovery and show synergistic effects with postinjury treadmill exercise in a muscle injury model in rats. Am J Sports Med 2021; 49: 1073-1085.
147. Contreras-Muñoz P, Torrella JR, Venegas V, Serres X, Vidal L, Vila I, et al. Muscle precursor cells enhance functional muscle recovery and show synergistic effects with postinjury treadmill exercise in a muscle injury model in rats. Am J Sport Med 2021; 49: 1073-1085.
148. Greising SM, Corona BT, McGann C, Frankum JK, Warren GL. Therapeutic approaches for volumetric muscle loss injury: A systematic review and meta-analysis. Tissue Eng Part B Rev 2019; 25: 510-525.
149. Świerczek-Lasek B, Tolak L, Bijoch L, Stefaniuk M, Szpak P, Kalaszczynska I, et al. Comparison of muscle regeneration after BMSC-conditioned medium, syngeneic, or allogeneic BMSC injection. Cells 2022; 11: 2843.
150. Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, et al. Ethical and safety issues of stem cell-based therapy. Int J Med Sci 2018; 15: 36-45.
151. Cezar CA, Mooney DJ. Biomaterial-based delivery for skeletal muscle repair. Adv Drug Deliv Rev 2015; 84: 188–197.
152. Law L, Hunt CL, Van Wijnen AJ, Nassr A, Larson AN, Eldrige JS, et al. Office-based mesenchymal stem cell therapy for the treatment of musculoskeletal disease: A systematic review of recent human studies. Pain Med 2019; 20: 1570-1583.
153. Todd M, Kang S, Wu S, Adhin D, Yoon DY, Willcocks R, et al. Use of imaging biomarkers and ambulatory functional endpoints in Duchenne muscular dystrophy clinical trials: Systematic review and machine learning-driven trend analysis. J Neuromuscul Dis 2025; 22143602251360664.
154. Thompson M, Mei SHJ, Wolfe D, Champagne J, Fergusson D, Stewart DJ, et al. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis. EClinicalMedicine. 2020; 19: 100249.
155. Muthu S, Jeyaraman M, Gulati A, Arora A. Current evidence on mesenchymal stem cell therapy for traumatic spinal cord injury: Systematic review and meta-analysis. Cytotherapy 2021; 23: 186-197.
156. Hamidian Jahromi S, Davies JE. Concise review: Skeletal muscle as a delivery route for mesenchymal stromal cells. Stem Cells Transl Med 2019; 8: 456-465.
157. Yamaguchi N, Horio E, Sonoda J, Yamagishi M, Miyakawa S, Murakami F, et al. Immortalization of mesenchymal stem cells for application in regenerative medicine and their potential risks of tumorigenesis. Int J Mol Sci 2024; 25: 13562.
158. Sanabria-de La Torre R, Quiñones-Vico MI, Fernández-González A, Sánchez-Díaz M, Montero-Vílchez T, Sierra-Sánchez Á, et al. Alloreactive immune response associated to human mesenchymal stromal cells treatment: A systematic review. J Clin Med 2021; 10: 2991.
159. Han Y, Hao S, Hu L, Rao S, Hou Z, Cheng T. Generation of hypoimmunogenic hematopoietic stem cells and their potential application in HSCT. Blood 2024; 144: 7460.
160. Hynes JP, Fhlatharta MN, Ryan JW, MacMahon PJ, Eustace SJ, Kavanagh EC. Complications in image-guided musculoskeletal injections. Skeletal Radiol 2021; 50: 343-349.
161. Li M, Lim D, Tang KF, Lim S, Boey K. Microbial contamination in umbilical cord blood: a comparison before and after cryopreservation. Stem Cells Transl Med 2018; 7: S2.
162. Williamson J, Spicer AJ, Colcomb P-A. The effect of the RMAT designation on biotechnology stock prices, drug development timelines and outcomes: An empirical analysis. J Pharm Res Int 2024; 36: 1-15.
163. Iglesias-Lopez C, Obach M, Vallano A, Agustí A. Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States. Cytotherapy 2021; 23: 261–274.
164. Gomes KLG, Da Silva RE, Da Silva Junior JB, Novaes MRCG. Comparison of new Brazilian legislation for the approval of advanced therapy medicinal products with existing systems in the USA, European Union and Japan. Cytotherapy 2022; 24: 557-566.
165. Pigeau GM, Csaszar E, Dulgar-Tulloch A. Commercial scale manufacturing of allogeneic cell therapy. Front Med 2018; 5: 233.
166. Zhang C, Zhou L, Wang Z, Gao W, Chen W, Zhang H, et al. Eradication of specific donor-dependent variations of mesenchymal stem cells in immunomodulation to enhance therapeutic values. Cell Death Dis 2021; 12: 357.
167. Wang J, Griffiths E, Tounekti O, Nemec M, Deneault E, Lavoie JR, et al. Canadian regulatory framework and regulatory requirements for cell and gene therapy products. Adv Exp Med Biol 2023; 1430: 91-116.
168. Jørgensen J, Kefalas P. The use of innovative payment mechanisms for gene therapies in Europe and the USA. Regen Med 2021; 16: 405–422.
169. Qiu T, Pochopień M, Hanna E, Liang S, Wang Y, Han R, et al. Challenges in the market access of regenerative medicines, and implications for manufacturers and decision-makers: A systematic review. Regen Med 2022; 17: 119-139.
170. Calcat-i-Cervera S, Rendra E, Scaccia E, Amadeo F, Hanson V, Wilm B, et al. Harmonised culture procedures minimise but do not eliminate mesenchymal stromal cell donor and tissue variability in a decentralised multicentere manufacturing approach. Stem Cell Res Ther 2023; 14: 120.
171. Amini A, Chien S, Bayat M. Impact of ultrasound therapy on stem cell differentiation-a systematic review. Curr Stem Cell Res Ther 2020; 15: 462–472.
172. Edmonds PD, Abramowicz JS, Carson PL, Carstensen EL, Sandstrom KL. Guidelines for journal of ultrasound in medicine authors and reviewers on measurement and reporting of acoustic output and exposure. J Ultrasound Med 2005; 24: 1171–1179.
173. Jayaraman P, Lim R, Ng J, Vemuri MC. Acceleration of translational mesenchymal stromal cell therapy through consistent quality GMP manufacturing. front cell dev biol. 2021; 9: 648472.
174. Samsonraj RM, Rai B, Sathiyanathan P, Puan KJ, Rötzschke O, Hui JH, et al. Establishing criteria for human mesenchymal stem cell potency. Stem Cells 2015; 33: 1878-1891.
175. Avey MT, Moher D, Sullivan KJ, Fergusson D, Griffin G, Grimshaw JM, et al. The devil is in the details: Incomplete reporting in preclinical animal research. PLoS One 2016; 11: e0166733.
176. Mwikirize C, Nosher JL, Hacihaliloglu I. Convolution neural networks for real-time needle detection and localization in 2D ultrasound. Int J Comput Assist Radiol Surg 2018; 13: 647–657.
177. Zhao Y, Shen Y, Bernard A, Cachard C, Liebgott H. Evaluation and comparison of current biopsy needle localization and tracking methods using 3D ultrasound. Ultrasonics 2017; 73: 206-220.
178. Rabani R, Chahal J, Mahomed N, Marshall K, Gandhi R, Viswanathan S. Microrna profile of mesenchymal stromal cells: A tool to predict their therapeutic efficasy in osteoarthritis. Cytotherapy 2020; 22: S99.
179. Sun W, Li Z, Zhou X, Yang G, Yuan L. Efficient exosome delivery in refractory tissues assisted by ultrasound-targeted microbubble destruction. Drug Deliv 2019; 26: 45-50.
)